Stem cell-derived exosomes as neurotherapeutic agents: mechanisms of immunomodulation and neural regeneration in neurodegenerative disorders
Open Access
- 27 January 2026
- journal article
- Published by Open Exploration Publishing in Exploration of Neuroprotective Therapy
- Vol. 6
Abstract
Neurodegenerative disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and ischemic stroke cause progressive and often irreversible neuronal loss, leading to major functional disability. Conventional pharmacological therapies primarily offer symptomatic relief and fail to promote neuro-restoration. Stem cell-derived exosomes have recently gained attention as acellular, regenerative biologics capable of modulating inflammation, enhancing synaptic repair, and facilitating neural recovery. These nanoscale vesicles carry bioactive molecules, including microRNAs (miRNAs) and growth factors, that replicate many of the paracrine benefits of stem cells without the associated risks of tumorigenicity or immune rejection. The objective of this review is to critically evaluate recent evidence on the neuroprotective, immunomodulatory, and translational mechanisms of stem cell-derived exosomes in major neurodegenerative and cerebrovascular disorders, highlighting their clinical relevance and therapeutic potential. Preclinical studies suggest that exosome administration may restore mitochondrial function, reduce oxidative stress, and support neuronal survival, with associated improvements in cognitive and motor outcomes in experimental models of AD, PD, and stroke. Exosomal miRNAs such as miR-21, miR-124, and miR-133b mediate neuroprotective effects through phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt), mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK), and nuclear factor erythroid 2-related factor 2 (Nrf2) signaling, while miR-146a promotes immunomodulation by suppressing pro-inflammatory cytokines and facilitating microglial repair phenotypes. Early-phase clinical studies primarily demonstrate feasibility and short-term safety, with exploratory signals of neurological improvement that require confirmation in adequately powered trials. Despite challenges in standardization and regulation, exosome-based therapy represents a scalable, safe, and clinically translatable strategy for neuro-regeneration, with significant promise for future management of brain network disorders.Keywords
This publication has 59 references indexed in Scilit:
- Multifunctional Conductive and Electrogenic Hydrogel Repaired Spinal Cord Injury via Immunoregulation and Enhancement of Neuronal DifferentiationAdvanced Materials, 2024
- Exosomes‐Loaded Electroconductive Hydrogel Synergistically Promotes Tissue Repair after Spinal Cord Injury via Immunoregulation and Enhancement of Myelinated Axon GrowthAdvanced Science, 2022
- Stem Cell-Derived Exosomes: a New Strategy of Neurodegenerative Disease TreatmentMolecular Neurobiology, 2021
- Extracellular vesicles as drug delivery systems: Why and how?Advanced Drug Delivery Reviews, 2020
- Neural stem cell derived extracellular vesicles: Attributes and prospects for treating neurodegenerative disordersEBioMedicine, 2018
- Enhanced proangiogenic potential of mesenchymal stem cell-derived exosomes stimulated by a nitric oxide releasing polymerBiomaterials, 2017
- Immunomodulatory effects of mesenchymal stromal cells-derived exosomeImmunologic Research, 2016
- Near infrared laser stimulation of human neural stem cells into neurons on graphene nanomesh semiconductorsColloids and Surfaces B: Biointerfaces, 2015
- MiR-133b Promotes Neural Plasticity and Functional Recovery After Treatment of Stroke with Multipotent Mesenchymal Stromal Cells in Rats Via Transfer of Exosome-Enriched Extracellular ParticlesStem Cells, 2013
- Exosome-Mediated Transfer of miR-133b from Multipotent Mesenchymal Stromal Cells to Neural Cells Contributes to Neurite OutgrowthStem Cells, 2012